FDA Drops PATH Wave 8 Data — Nicotine Pouch-usage in focus!
The FDA just released Wave 8 of the PATH Study, the federal government's most comprehensive look at nicotine pouch usage in America. Here's what the data covers.
The FDA released Wave 8 data from its Population Assessment of Tobacco and Health (PATH) Study — the federal government's long-running survey of tobacco and nicotine product use across America.
If you follow the nicotine pouch market, this is the dataset. PATH is the most-watched source for usage trends in the US, and Wave 8 marks the latest snapshot of how Americans are using pouches, cigarettes, vapes, and everything in between.
What PATH Wave 8 Covers
The newly released dataset tracks tobacco and nicotine product usage patterns among US adults and youth. That includes nicotine pouches — the category regulators, manufacturers, and investors have been watching closely as it continues its rapid growth.
PATH surveys are conducted in waves, with each wave representing a multi-year data collection period. Wave 8 continues the longitudinal study that began in 2013, providing one of the most comprehensive looks at how nicotine use is shifting in real time.
Why This Matters
PATH data isn't just academic — it directly informs FDA regulatory decisions. Previous waves have been cited in flavor ban debates, PMTA reviews, and youth prevention policy. Wave 8's pouch numbers will likely shape how regulators view the category's risk profile, especially as the FDA continues to evaluate pouch products under its premarket review process.
For the industry, PATH is the reality check. Company earnings calls cite vague "strong consumer adoption," but PATH shows who's actually using these products, how often, and whether they're switching from cigarettes or picking up nicotine for the first time.
What's Next
The raw dataset is now available, but detailed analysis from researchers typically follows in the months ahead. Expect breakdowns of dual-use patterns (pouch + cigarette users), age demographics, and how pouch adoption compares to previous waves.
The FDA has not yet released a public summary of Wave 8 findings, but the data is accessible to researchers and public health analysts.
SOURCES:
- Tobacco Reporter: FDA Releases PATH Study Data from Wave 8
Where to buy: Available from select retailers. Compare prices at PouchFinder.